Enhancing Cardiac Cell Differentiation from Induced Pluripotent Stem Cells with Cyclosporin-A
Author Information
Author(s): Fujiwara Masataka, Yan Peishi, Otsuji Tomomi G., Narazaki Genta, Uosaki Hideki, Fukushima Hiroyuki, Kuwahara Koichiro, Harada Masaki, Matsuda Hiroyuki, Matsuoka Satoshi, Okita Keisuke, Takahashi Kazutoshi, Nakagawa Masato, Ikeda Tadashi, Sakata Ryuzo, Mummery Christine L., Nakatsuji Norio, Yamanaka Shinya, Nakao Kazuwa, Yamashita Jun K.
Primary Institution: Kyoto University, Kyoto, Japan
Hypothesis
Can cyclosporin-A enhance the differentiation of cardiac cells from mouse and human induced pluripotent stem cells?
Conclusion
Cyclosporin-A significantly increases the differentiation of cardiac progenitor cells and functional cardiomyocytes from both mouse and human induced pluripotent stem cells.
Supporting Evidence
- Cyclosporin-A treatment increased the number of beating cardiomyocytes by 12-fold in mouse iPSCs.
- Human iPSC-derived cardiomyocytes showed expected molecular and functional features after treatment with cyclosporin-A.
- Approximately 39% of total colonies included beating cardiomyocytes under optimized conditions.
Takeaway
Researchers found that a drug called cyclosporin-A helps turn special stem cells into heart cells, which could help in heart treatments.
Methodology
The study involved co-culturing induced pluripotent stem cells with specific stroma cells and adding cyclosporin-A to enhance cardiomyocyte differentiation.
Limitations
The study primarily focuses on the effects of cyclosporin-A and does not explore other potential methods for enhancing differentiation.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website